Anke Stroyer

Title: Anke Stroyer: Innovator in Pharmaceutical Sciences

Introduction

Anke Stroyer is a notable inventor based in Berlin, Germany, recognized for her contributions to the field of pharmaceutical sciences. With two patents to her name, Anke has made significant advancements in the development of modified-release pharmaceutical dosage forms.

Latest Patents

Anke's latest patents focus on orally administrable modified-release pharmaceutical dosage forms. These innovations involve sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate. The research outlines processes for preparing these dosage forms and their applications in treating or preventing various diseases, including cardiac, renal, and pulmonary disorders, as well as central nervous system disorders, fibrotic and inflammatory disorders, and metabolic disorders.

Career Highlights

Anke began her impactful career working with prominent companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her experience in these leading pharmaceutical organizations has equipped her with extensive knowledge and skills in research and development.

Collaborations

Throughout her career, Anke has worked alongside notable colleagues such as Carmen Lobback and Peter Serno. These collaborations have contributed to her innovative projects and have fostered the development of groundbreaking pharmaceutical solutions.

Conclusion

Anke Stroyer's dedication to improving pharmaceutical formulations demonstrates her commitment to innovation in healthcare. Her work is instrumental in addressing critical health challenges through effective medication delivery systems, paving the way for better patient outcomes.